Is a ferritin level of 165 considered normal in a patient with erythrocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Elevated Ferritin in Erythrocytosis: Interpretation and Clinical Significance

A ferritin level of 165 is not abnormal in a patient with erythrocytosis and may actually be appropriate given the increased red cell mass and iron utilization that occurs in this condition. This level falls within expected ranges and does not necessarily indicate iron overload requiring intervention.

Understanding Ferritin in Erythrocytosis

Erythrocytosis is characterized by increased red blood cell production, which naturally requires more iron utilization. In this context, ferritin levels should be interpreted differently than in the general population:

  • Normal ferritin ranges vary by sex: approximately 135 μg/L for men and 43 μg/L for women in the United States 1
  • A ferritin level of 165 μg/L is only slightly above the average for males and would not be considered pathologically elevated
  • In erythrocytosis, maintaining adequate iron stores is essential for effective erythropoiesis

Clinical Implications and Management

When to Be Concerned About Ferritin Levels

  • Too low: Ferritin <100 μg/L in erythrocytosis patients may indicate inadequate iron stores for the increased red cell production 1
  • Too high: Chronic ferritin levels >800 μg/L may suggest iron overload requiring monitoring 1
  • Intermediate values (100-800 μg/L): Generally appropriate for patients with increased red cell mass

Importance of Adequate Iron in Erythrocytosis

Maintaining sufficient iron stores in erythrocytosis is crucial because:

  • Iron deficiency in erythrocytosis can lead to production of microcytic (small) red blood cells with reduced oxygen-carrying capacity 1
  • Iron-deficient red cells are less deformable, which may increase the risk of stroke in patients with cyanotic conditions 1
  • Aggressive phlebotomy without monitoring iron status can deplete iron stores and worsen clinical outcomes 1

Interpreting Ferritin in Context

Always evaluate ferritin alongside other parameters:

  • Transferrin saturation (TSAT): Provides insight into circulating iron available for erythropoiesis 1
  • Complete blood count: Assess for microcytosis or other abnormalities that might suggest iron deficiency despite normal ferritin 1
  • Clinical status: Consider whether inflammation is present, as ferritin is an acute phase reactant that increases with inflammation 1

Common Pitfalls in Ferritin Interpretation

  1. Failing to recognize that ferritin is an acute phase reactant: Inflammation can elevate ferritin independent of iron status 1

  2. Applying standard reference ranges without context: Erythrocytosis patients require different interpretation of iron parameters due to their increased iron utilization

  3. Performing unnecessary phlebotomies: Repetitive phlebotomies without clear indication (Hgb >20 g/dL and Hct >65% with symptoms) can lead to iron depletion and complications 1

  4. Overlooking the relationship between ferritin and red cell production: Erythrocyte ferritin reflects the balance between iron supply and utilization for hemoglobin synthesis 2

In conclusion, a ferritin level of 165 in a patient with erythrocytosis should not raise immediate concerns and is likely appropriate for the increased red cell production. Focus should remain on monitoring for symptoms of hyperviscosity, maintaining adequate but not excessive iron stores, and addressing the underlying cause of erythrocytosis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical relevance of erythrocyte ferritin in microcytic anemias.

Clinica chimica acta; international journal of clinical chemistry, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.